Immune Design Corp. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Immune Design Corp. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$51.67 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2019-03-13
- Immune Design Corp. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-03-31 was -$17.38M.
- Immune Design Corp. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-12-31 was -$4.38M.
- Immune Design Corp. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-09-30 was -$10.92M.
- Immune Design Corp. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-06-30 was -$8.30M.
- Immune Design Corp. net cash provided by (used in) operating activities, continuing operations for fiscal 2018 was -$51.67M.
- Immune Design Corp. net cash provided by (used in) operating activities, continuing operations for fiscal 2017 was -$46.86M.
- Immune Design Corp. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$35.74M.
- Immune Design Corp. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$37.80M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | -$51.67M 10-K · filed 2019-03-13 | ||||
| 2017-12-31 | -$46.86M 10-K · filed 2019-03-13 | -$53.06M 10-K · filed 2018-03-14 | |||
| 2017-03-31 | -$17.38M 10-Q · filed 2017-05-04 | -$21.76M derived: sum of 2 quarters · filed 2019-03-13 | -$32.68M derived: sum of 3 quarters · filed 2019-03-13 | -$40.98M derived: sum of 4 quarters · filed 2019-03-13 | |
| 2016-12-31 | -$4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$15.30M derived: sum of 2 quarters · filed 2019-03-13 | -$23.60M derived: sum of 3 quarters · filed 2019-03-13 | -$35.74M 10-K · filed 2019-03-13 | |
| 2016-09-30 | -$10.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$19.22M derived: sum of 2 quarters · filed 2016-11-09 | -$31.36M 10-Q · filed 2016-11-09 | -$38.90M derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-06-30 | -$8.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$20.44M 10-Q · filed 2016-08-09 | -$27.98M derived: sum of 3 quarters · filed 2018-03-14 | -$36.58M derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-03-31 | -$12.14M 10-Q · filed 2017-05-04 | -$19.68M derived: sum of 2 quarters · filed 2018-03-14 | -$28.28M derived: sum of 3 quarters · filed 2018-03-14 | -$35.00M derived: sum of 4 quarters · filed 2018-03-14 | |
| 2015-12-31 | -$7.54M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$16.14M derived: sum of 2 quarters · filed 2018-03-14 | -$22.86M derived: sum of 3 quarters · filed 2018-03-14 | -$37.80M 10-K · filed 2018-03-14 | |
| 2015-09-30 | -$8.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$15.32M derived: sum of 2 quarters · filed 2016-11-09 | -$30.26M 10-Q · filed 2016-11-09 | -$38.14M derived: sum of 4 quarters · filed 2017-03-07 | |
| 2015-06-30 | -$6.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$21.66M 10-Q · filed 2016-08-09 | -$29.54M derived: sum of 3 quarters · filed 2017-03-07 | -$31.43M derived: sum of 4 quarters · filed 2017-03-07 | |
| 2015-03-31 | -$14.94M 10-Q · filed 2016-05-10 | -$22.83M derived: sum of 2 quarters · filed 2017-03-07 | -$24.71M derived: sum of 3 quarters · filed 2017-03-07 | -$30.47M derived: sum of 4 quarters · filed 2017-03-07 | |
| 2014-12-31 | -$7.88M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | -$9.77M derived: sum of 2 quarters · filed 2017-03-07 | -$15.53M derived: sum of 3 quarters · filed 2017-03-07 | -$20.67M 10-K · filed 2017-03-07 | |
| 2014-09-30 | -$1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$7.64M derived: sum of 2 quarters · filed 2015-11-12 | -$12.78M 10-Q · filed 2015-11-12 | -$16.84M derived: sum of 4 quarters · filed 2016-03-15 | |
| 2014-06-30 | -$5.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$10.90M 10-Q · filed 2015-08-12 | -$14.96M derived: sum of 3 quarters · filed 2016-03-15 | -$17.33M derived: sum of 4 quarters · filed 2016-03-15 | |
| 2014-03-31 | -$5.14M 10-Q · filed 2015-05-14 | -$9.20M derived: sum of 2 quarters · filed 2016-03-15 | -$11.57M derived: sum of 3 quarters · filed 2016-03-15 | ||
| 2013-12-31 | -$4.06M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$6.43M derived: sum of 2 quarters · filed 2016-03-15 | -$14.30M 10-K · filed 2016-03-15 | ||
| 2013-09-30 | -$2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$10.24M 10-Q · filed 2014-11-13 | |||
| 2013-06-30 | -$7.86M 10-Q · filed 2014-09-08 | ||||
| 2012-12-31 | -$9.58M 10-K · filed 2015-03-31 |